AJP - GI Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Gastrointest Liver Physiol 281: G8-G15, 2001;
0193-1857/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sternini, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sternini, C.
Vol. 281, Issue 1, G8-G15, July 2001

THEME
Receptors and Transmission in the Brain-Gut Axis: Potential for Novel Therapies
III. µ-Opioid receptors in the enteric nervous system

Catia Sternini

CURE Digestive Diseases Research Center, Department of Veterans Affairs Greater Los Angeles Healthcare System, Digestive Diseases Division, Departments of Medicine and Neurobiology, University of California, Los Angeles, California 90095

G protein-coupled receptors are cell surface signal-transducing proteins, which elicit a variety of biological functions by the activation of different intracellular effector systems. Many of these receptors, including the µ-opioid receptor (µOR), have been localized in the gastrointestinal tract. µOR is the target of opioids and alkaloids, potent analgesic drugs with high potential for abuse. µOR is expressed by enteric neurons, and it undergoes ligand-selective endocytosis. It is of clinical importance because it mediates tolerance and other major side effects of opiate analgesics, including impairment of gastrointestinal propulsion. An important observation of µOR is its differential trafficking and desensitization properties in response to individual agonists, which might have long-term physiological consequences and be involved in the development of opiate side effects. Receptor activation by agonists is the basis for signaling, and alterations of the mechanisms controlling cellular responses of G protein-coupled receptors to agonists might be the basis of several diseases, including gastrointestinal diseases. Therefore, understanding these basic cellular mechanisms is important for developing appropriate therapeutic agents.

G protein-coupled receptors; receptor endocytosis; motoneurons; receptor trafficking


This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
E. R. Viscusi, T. J. Gan, J. B. Leslie, J. F. Foss, M. D. Talon, W. Du, and G. Owens
Peripherally Acting Mu-Opioid Receptor Antagonists and Postoperative Ileus: Mechanisms of Action and Clinical Applicability
Anesth. Analg., June 1, 2009; 108(6): 1811 - 1822.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
D Philippe, D Chakass, X Thuru, P Zerbib, A Tsicopoulos, K Geboes, P Bulois, M Breisse, H Vorng, J Gay, et al.
Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation
Gut, June 1, 2006; 55(6): 815 - 823.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
K. N. Browning, A. E. Kalyuzhny, and R. A. Travagli
{micro}-Opioid Receptor Trafficking on Inhibitory Synapses in the Rat Brainstem
J. Neurosci., August 18, 2004; 24(33): 7344 - 7352.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online